US Patent Issued to Laboratoires Expanscience on Feb. 10 for "Composition comprising at least one oxazoline for inhibiting the growth of Malassezia yeasts involved in cradle cap, in particular" (French Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,361, issued on Feb. 10, was assigned to Laboratoires Expanscience (Paris la Defense, France).

"Composition comprising at least one oxazoline for inhibiting the growth of Malassezia yeasts involved in cradle cap, in particular" was invented by Stephanie Bredif (Croisilles, France), Sophie Leclere-Bienfait (Dreux, France) and David Durancet (Saint Cyr l'Ecole, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising at least one oxazoline, such as OX100, for inhibiting the growth of Malassezia yeasts and/or for preventing and/or treating conditions caused by Malassezia yeasts, seborrheic dermatiti...